The assessment of vasoactive properties of CGRP and adrenomedullin in the microvasculature: A study using in vivo and in vitro assays in the mouse

Journal of Molecular Neuroscience

Volumn 22, Issue 1-2, 2004, Pages 117-124

  Tam, Christina ^a   Brain, Susan D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Adrenomedullin; CGRP; Microvasculature; Mouse; Vasoactive

Indexed keywords

ADRENOMEDULLIN; ALBUMIN I 125; CALCITONIN GENE RELATED PEPTIDE; NEUROPEPTIDE; PROSTAGLANDIN D2; PROSTAGLANDIN E1; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE; VASODILATOR AGENT; ALBUMINOID; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD FLOW; BLOOD VESSEL PERMEABILITY; BOLUS INJECTION; CONFERENCE PAPER; DNA MODIFICATION; DOSE RESPONSE; DRUG POTENCY; EDEMA; EXTRAVASATION; EXTRAVASCULAR SPACE; IN VIVO STUDY; MEASUREMENT; MESENTERY; MICROVASCULATURE; MOUSE; NONHUMAN; PERFUSION PRESSURE; QUANTITATIVE ANALYSIS; RAT; SKIN; VASODILATATION; ANIMAL; ARTICLE; BLOOD VESSEL; CAPILLARY PERMEABILITY; DRUG EFFECT; MESENTERIC ARTERY; METABOLISM; MICROCIRCULATION; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ADRENOMEDULLIN; ALBUMINS; ALPROSTADIL; ANIMALS; BLOOD VESSELS; CALCITONIN GENE-RELATED PEPTIDE; CAPILLARY PERMEABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; MESENTERIC ARTERIES; MICE; MICROCIRCULATION; MUSCLE, SMOOTH, VASCULAR; PEPTIDES; RATS; REGIONAL BLOOD FLOW; SUBSTANCE P; VASOACTIVE INTESTINAL PEPTIDE; VASODILATION; VASODILATOR AGENTS;

EID: 3042703994     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:22:1-2:117     Document Type: Conference Paper

References (23)

1. Amerini S., Mantelli L., and Ledda F. (1993) Nitric oxide is not involved in the effects induced by non-adrenergic non-cholinergic stimulation and calcitonin gene-relate d peptide in the rat mesenteric vascular bed. Neuropeptides 25, 51-55.
2. Asanuma Y., Sato T., Kato T., Nanjo H., Kurokawa T., Yasui O., et al. (2002) Continuous arterial infusion of prostaglandin E(1) via the superior mesenteric artery in the treatment of postoperative liver failure. Ther. Apher. 6, 89-92.
3. Berthiaume N., Hess F., Chen A., Regoli D., and D'Orleans-Juste P. (1997) Pharmacology of kinins in the arterial and venous mesenteric bed of normal and B2 knockout transgenic mice. Eur. J. Pharmacol. 333, 55-61.
4. Brain S. D., Poyner D. R., and Hill R. G. (2002) CGRP receptors: a headache to study, but will antagonists prove therapeutic in migraine? Trends Pharmacol. Sci. 23, 51-53.
5. Brain S. D. and Williams T. J. (1985) Inflammatory oedema induced by synergism between calcitonin gene- related peptide (CGRP) and mediators of increased vascular permeability. Br. J. Pharmacol. 86, 855-860.
6. Brain S. D. and Williams T. J. (1988) Substance P regulates the vasodilator activity of calcitonin gene- related peptide. Nature 335, 73-75.
7. Brain S. D., Williams T. J., Tippins J. R., Morris H. R., and MacIntyre I. (1985) Calcitonin gene-related peptide is a potent vasodilator. Nature 313, 54-56.
8. Chiba T., Yamaguchi A., Yamatani T., Nakamura A., Morishita T., Inui T., et al. (1989) Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am. J. Physiol 256, E331-E335.
9. Chu D. Q., Choy M., Foster P., Cao T., and Brain S. D. (2000) A comparative study of the ability of calcitonin gene-related peptide and adrenomedullin(13-52) to modulate microvascular but not thermal hyperalgesia responses. Br. J. Pharmacol. 130, 1589-1596.
10. Chu D. Q., Legon S., Smith D. M., Costa S. K., Cuttitta F., and Brain S. D. (2001) The calcitonin gene-related peptide (CGRP) antagonist CGRP(8-37) blocks vasodilatation in inflamed rat skin: involvement of adrenomedullin in addition to CGRP. Neurosci. Lett. 310, 169-172.
11. Doods H., Hallermayer G., Wu D., Entzeroth M., Rudolf K., Engel W., et al. (2000) Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br. J. Pharmacol. 129, 420-423.
12. Escott K. J. and Brain S. D. (1993) Effect of a calcitonin gene-related peptide antagonist (CGRP8-37) on skin vasodilatation and oedema induced by stimulation of the rat saphenous nerve. Br. J. Pharmacol. 110, 772-776.
13. Grant A. D., Gerard N. P., and Brain S. D. (2002) Evidence of a role for NK1 and CGRP receptors in mediating neurogenic vasodilatation in the mouse ear. Br. J. Pharmacol. 135, 356-362.
14. Kawasaki H., Takasaki K., Saito A., and Goto K. (1988) Calcitonin gene-related peptide acts as anovel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature 335, 164-167.
15. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., et al. (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192, 553-560.
16. Lundberg J. M., Franco-Cereceda A., Hua X., Hokfelt T., and Fischer J. A. (1985) Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur. J. Pharmacol. 108, 315-319.
17. Marutsuka K., Hatakeyama K., Sato Y., Yamashita A., Sumiyoshi A., and Asada Y. (2003) Immunohistological localization and possible functions of adrenomedullin. Hypertens. Res. 26 Suppl, S33-S40.
18. McLatchie L. M., Fraser N. J., Main M. J., Wise A., Brown J., Thompson N., et al. (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393, 333-339.
19. Nuki C., Kawasaki H., Kitamura K., Takenaga M., Kangawa K., Eto T., et al. (1993) Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem. Biophys. Res. Commun. 196, 245-251.
20. Ottesen B. and Fahrenkrug J. (1981) Effect of vasoactive intestinal polypeptide (VIP) upon myometrial blood flow in non-pregnant rabbit. Acta Physiol Scand. 112, 195-201.
21. Sugo S., Minamino N., Shoji H., Kangawa K., Kitamura K., Eto T., et al. (1994) Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha. Biochem. Biophys. Res. Commun. 203, 719-726.
22. Williams T. J. (1982) Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin. Br. J. Pharmacol. 77, 505-509.
23. Williams T. J. and Peck M. J. (1977) Role of prostaglandin-mediated vasodilatation in inflammation. Nature 270, 530-532.